Collegium – which sells opioid analgesics under the Xtampza (oxycodone) and Nucynta (tapentadol) brands – has agreed to pay $5.60 per share in cash for BDSI, valuing the company at around $604 ...

The two visited Słubice's Collegium Polonicum academic institution on the Polish side, then joined a festival and crossed the Oder Bridge to Frankfurt an der Oder in Germany. Baerbock called May ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Collegium Pharmaceutical, Inc. stock fell 16% on Friday after Q1 results missed expectations and a CEO replacement was announced. Despite the negative reaction, there were some positive aspects in ...

The Helsinki Collegium for Advanced Studies is an independent institute of advanced study within the University of Helsinki. It provides a top-class, international research environment for scholars in ...

STOUGHTON, Mass., April 29, 2024 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified specialty pharmaceutical company committed to improving the lives of ...

The Helsinki Collegium selects fellows through a competitive and international application process. The 2024 Core Fellowship call opens in mid-August 2024 and closes in mid-September 2024 (exact dates ...

Collegium Pharmaceutical, Inc. is a pharmaceutical company, which engages in development and planning to commercialize next generation, abuse-deterrent products for the treatment of patients ...

Collegium Pharmaceutical, Inc. is a pharmaceutical company, which engages in development and planning to commercialize next generation, abuse-deterrent products for the treatment of patients ...

STOUGHTON, Mass., April 25, 2024 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified specialty pharmaceutical company committed to improving the lives of ...